SSG Advises Eiger BioPharmaceuticals Inc. in the Sale of Lonafarnib and Lambda Program Assets to Eiger InnoTherapeutics, Inc.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of Lonafarnib and Lambda, and associated clinical assets to Eiger InnoTherapeutics, Inc. The sale was effectuated through a….
READ MORESSG Places Debt Financing for Pegasus Home Fashions
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Pegasus Home Fashions, Inc. and its affiliated entities (collectively, “Pegasus” or the “Company”) in the private placement of a $25 million revolving credit facility with Ares Management, LLC. The….
READ MORESSG Advises ICON Aircraft, Inc. in the Sale of Substantially All Assets to an Affiliate of Dürkopp Adler GmbH
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to ICON Aircraft, Inc. (“ICON” or the “Company”) in the sale of substantially all assets to an affiliate of Dürkopp Adler GmbH (“DA”). The sale was effectuated through a….
READ MORESSG Advises the Chapter 7 Trustee of Gelesis Holdings Inc. in the Sale of Substantially All Assets to an Affiliate of Theras Group S.r.l.
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to George L. Miller, the Chapter 7 Trustee (“Trustee”) of Gelesis Holdings Inc. and certain affiliates (collectively, “Gelesis” or the “Company”), in the sale of substantially all assets to….
READ MORESSG Advises Eiger BioPharmaceuticals, Inc. in the Sale of Avexitide Program Assets to Amylyx Pharmaceuticals
SSG Capital Advisors, LLC (“SSG”) served as the investment banker to Eiger BioPharmaceuticals, Inc. (“Eiger” or the “Company”) in the sale of Avexitide and its related clinical assets to Amylyx Pharmaceuticals, Inc. The sale was effectuated through a Chapter….
READ MORE